AI assistant
CENTENE CORP — Director's Dealing 2022
Nov 30, 2022
30343_dirs_2022-11-29_d0874813-a9d4-4192-9aa9-b491938566ec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CENTENE CORP (CNC)
CIK: 0001071739
Period of Report: 2022-11-25
Reporting Person: FASOLA KENNETH J (EVP, Health Care Enterprises)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-11-25 | Phantom Stock | $0.0 | A | 23.915 | Acquired | 2022-11-25 | Common Stock (23.915) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 182536 | Direct |
Footnotes
F1: Ownership includes 161,543 shares of restricted stock subject to vesting requirements.
F2: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock.
F3: The phantom stock was acquired by Mr. Fasola through regularly scheduled payroll contributions to the Company's deferred compensation plan.
F4: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect.